(XLV) Health Care Sector SPDR - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US81369Y2090 • Health

XLV: Pharmaceuticals, Equipment, Biotechnology, Services, Technology

The Health Care Select Sector SPDR® Fund (XLV) is designed to track the performance of a specific index, employing a replication strategy to achieve this goal. This means the fund invests substantially all of its assets—specifically at least 95%—in the securities that make up the index it follows. By doing so, it aims to deliver returns that closely mirror the performance of the underlying index.

The fund focuses on companies operating across a broad spectrum of the health care sector. This includes pharmaceuticals, health care equipment and supplies, health care providers and services, biotechnology, life sciences tools and services, and health care technology. This diversified exposure allows investors to gain access to a wide range of businesses within the health care industry, from established pharmaceutical giants to innovative biotech firms.

Its important to note that the fund is classified as non-diversified. This means that it can invest a significant portion of its assets in a smaller number of companies or industries, which may lead to higher volatility compared to a diversified fund. Investors should consider this aspect when evaluating the funds potential risks and rewards.

The fund is listed under the ticker symbol XLV on the NYSE ARCA exchange and is categorized as a health care sector ETF. With a market capitalization or assets under management (AUM) of approximately $39.284 billion, it is one of the larger ETFs in its category. The funds focus on the health care sector makes it a popular choice for investors seeking exposure to this industry, which is often driven by factors such as demographic trends, medical innovation, and regulatory changes.

For more information about the fund, including its full holdings, performance data, and other details, investors can visit the official website at http://www.spdrs.com. The fund is domiciled in the United States.

Additional Sources for XLV ETF

XLV ETF Overview

Market Cap in USD 39,370m
Category Health
TER 0.09%
IPO / Inception 1998-12-16

XLV ETF Ratings

Growth 5y 68.5%
Fundamental -
Dividend 59.4%
Rel. Strength Industry -7.83
Analysts -
Fair Price Momentum 147.29 USD
Fair Price DCF -

XLV Dividends

Dividend Yield 12m 1.58%
Yield on Cost 5y 3.04%
Annual Growth 5y 6.32%
Payout Consistency 96.1%

XLV Growth Ratios

Growth Correlation 3m 82.3%
Growth Correlation 12m 23.5%
Growth Correlation 5y 90.5%
CAGR 5y 13.75%
CAGR/Max DD 5y 0.86
Sharpe Ratio 12m -0.37
Alpha -6.08
Beta 0.41
Volatility 13.63%
Current Volume 8040.8k
Average Volume 20d 7819.3k
What is the price of XLV stocks?
As of March 14, 2025, the stock is trading at USD 143.83 with a total of 8,040,826 shares traded.
Over the past week, the price has changed by -3.64%, over one month by -1.75%, over three months by +2.48% and over the past year by -0.24%.
Is Health Care Sector SPDR a good stock to buy?
Yes. Based on ValueRay Analyses, Health Care Sector SPDR (NYSE ARCA:XLV) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 68.51 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XLV as of March 2025 is 147.29. This means that XLV is currently overvalued and has a potential downside of 2.41%.
Is XLV a buy, sell or hold?
Health Care Sector SPDR has no consensus analysts rating.
What are the forecast for XLV stock price target?
According to ValueRays Forecast Model, XLV Health Care Sector SPDR will be worth about 161.4 in March 2026. The stock is currently trading at 143.83. This means that the stock has a potential upside of +12.2%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 161.4 12.2%